Pharmena S.A. (WSE:PHR)
Poland · Delayed Price · Currency is PLN 3.110
-0.050 (-1.58%)
Jul 24, 2026, 1:19 PM CET
Pharmena Financials Overview
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1.61 | 1.58 | 0.27 | 0.3 | 0.3 | 15.21 |
Revenue Growth | 146.54% | 488.43% | -10.37% | 0% | -98.04% | 53.16% |
Gross Profit Gross Profit Growth | 1.36 | 1.31 | 0.2 | -0 | 0.09 | 8.43 |
Operating Income Operating Income Growth | -3.17 | -3.28 | -3.38 | 32.81 | -4.06 | -4.05 |
Net Income Net Income Growth | -2.76 | -2.77 | -1.26 | 28.94 | -1.57 | -4.59 |
Earnings Per Share EPS Growth | -0.25 | -0.25 | -0.11 | 2.60 | -0.14 | -0.41 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Poland Poland Growth | 0.25 | 0.06 | 8.43 | 17.34 | 13.67 |
Foreign Foreign Growth | 1.32 | 0.21 | - | - | - |
Total Total Growth | 1.58 | 0.27 | 9.84 | 19.02 | 15.21 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.41 | 0.36 | 1.75 | 22.24 | 1.59 | 1.46 |
Total Debt Total Debt Growth | 0.34 | 0.37 | 0.24 | 0.18 | 10.14 | 9.71 |
Net Cash (Debt) Net Cash Growth | 0.07 | -0.01 | 1.5 | 22.05 | -8.55 | -8.25 |
Net Cash Growth | -88.51% | - | -93.19% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.01 | -0.00 | 0.13 | 1.98 | -0.77 | -0.74 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3.25 | -3.29 | -2.53 | 33.03 | 1.82 | -3.23 |
Capital Expenditures CapEx Growth | -0.36 | -0.24 | -0.18 | -0.31 | -0.23 | -0.32 |
Free Cash Flow Free Cash Flow Growth | -3.61 | -3.53 | -2.71 | 32.72 | 1.59 | -3.54 |
Free Cash Flow Growth | - | - | - | 1953.86% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 84.86% | 83.26% | 73.88% | -0.33% | 30.44% | 55.39% |
Operating Margin | -197.26% | -207.99% | -1262.31% | 10972.91% | -1358.19% | -26.65% |
Pretax Margin | -171.40% | -174.00% | -954.10% | 11011.71% | -1656.86% | -29.30% |
Profit Margin | -172.03% | -175.59% | -470.90% | 9679.26% | -525.08% | -30.19% |
FCF Margin | -225.11% | -223.65% | -1011.57% | 10942.48% | 532.78% | -23.30% |
| Fiscal Year | FY 2023 |
|---|---|
| Period Ending | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.850 |
Dividend Per Share Growth | - |
Dividend Yield | 13.27% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 2.73 | - | - |
Forward PE | - | 26.88 | 26.88 | 26.88 | 26.88 | 26.88 |
P/FCF Ratio | - | - | - | 2.42 | 39.15 | - |
PS Ratio | 21.58 | 18.36 | 159.17 | 264.48 | 208.60 | 5.79 |